<DOC>
	<DOC>NCT01009021</DOC>
	<brief_summary>The purpose of this study was to evaluate the analgesic effect of oral potassium diclofenac in patients with proliferative diabetic retinopathy submitted to retinal photocoagulation. Two groups of patients were followed and the effect of the treatment (diclofenac plus laser) was compared to placebo (placebo plus laser). Pain associated with treatment was recorded using a Visual Analog Scale 15 minutes after the procedure.</brief_summary>
	<brief_title>Oral Diclofenac for Retinal Photocoagulation in Diabetic Retinopathy</brief_title>
	<detailed_description />
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<criteria>1)highrisk proliferative diabetic retinopathy in both eyes 1)history of prior laser treatment or vitrectomy; 2) allergy to nonsteroidal antiinflammatory drugs; 3) any condition affecting comprehension of VAS pain score test; 4) Contraindications for diclofenac use such as pregnancy, bleeding disorders, asthma, or renal failure; 5) use of any analgesic drug for the last 24 hours.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>pain</keyword>
	<keyword>retinal photocoagulation</keyword>
	<keyword>potassium diclofenac</keyword>
</DOC>